American Association of Cancer Research (AACR) 2017 Annual Meeting - Insphero

American Association of Cancer Research (AACR) 2017 Annual Meeting


Apr 01 - 05, 2017

 

Accelerate oncology drug discovery and development

With physiologically relevant tumor models that reflect in vivo complexity

InSphero tumor microtissue model reflected
Visit InSphero at the AACR 2017 Annual Meeting to learn how our 3D InSight™ Oncology Services can help you accelerate development of anti-cancer drugs and immuno-therapeutic strategies, using 3D tumor spheroid models that more accurately reflect the complex biology of tumor microenvironments. We’ll also be previewing our new GravityTRAP™ 384 Microtissue Platform, a first-of-its-kind 384-well platform for high-throughput and high content imaging designed and optimized specifically for use with spheroids. Visit one of our posters, or join us at Booth 1029 to browse our in-booth poster hall.

 

 

 

 

What’s New at AACR 2017

3D InSight™ Immuno-oncology

Assess immune cell infiltration and tumor cell killing in vitro

The InSphero 3D InSight™ Oncology Services team can guide you through preclinical in vitro evaluation of your immuno-therapeutics in physiologically relevant 3D tumor microtissues.  Our 3D experts can build complex tumor spheroid models comprised of tumor, stromal, and immune components with the reproducibility required to ensure assay consistency and confidence in data interpretation.  

Potential applications include:

  • Immune cell infiltration
  • Tumor cell killing
  • Checkpoint inhibitor efficacy
  • Mono-or multi-specific antibody efficacy
  • Immuno-modulator activity

InSphero immuno oncology applications

 

Sneak Peek:  GravityTRAP™ 384 Microtissue Platform

Achieve superior HCI in 3D tumor spheroids 

384Well overview 01
At AACR 2017, we’ll be previewing our new GravityTRAP™ 384 Microtissue Platform, a spheroid-optimized high-throughput format for tumor microtissues compatible with today’s state-of-the-art liquid handling and high content imaging systems. You’ll soon be able to harness the benefits of working in more physiologically relevant 3D tumor spheroid models without the fear of aspirating your microtissues and with a flat glass base plate for superior imaging. Watch the video then stop by our booth to learn more.   

 

 

 

Your 3D InSight™ Conference Planner

Conference Dates
April 1-5, 2017

Venue
Walter E. Washington Convention Center, Washington, DC  USA

Booth
1029

Download the AACR Meeting App
View the AACR Online Meeting Planner

  Poster Presentations

See how the InSphero 3D Select™ Process is being applied to personalized therapeutic approaches for cancer

Wednesday April 5, 8:00 AM – 12:00 PM
5781/17 (Section 38): Establishment of a 3D ex-vivo assay as a preclinical drug testing platform for personalized cancer therapy

SDh rd 01

Presented by Dr. Sumeer Dhar, InSphero AG in collaboration with University of Zurich

 

Wednesday April 5, 8:00 AM – 12:00 PM
5780/16 (Section 38): 3D ex-vivo assay platform using primary lung cancer cells in malignant pleural effusions as predictors for clinical outcome of personalized chemotherapy

Presented by Cheng-guang Wu, University of Zurich

In-booth Poster Hall

AACR2017 booth poster insphero oncology platform

Accelerate Drug Discovery and Development with InSphero’s Oncology Platform

AACR2017 booth poster immuno oncology

Evaluate efficacy of immuno-therapeutics in biologically relevant 3D cancer microtissue models

AACR2017 booth poster NCATS phenotypic screening

Multi-parametric 3D tumor microtissue-based phenotypic compound classification

AACR2017 booth poster tumor relapse

Assessment of tumor recurrence with an in vitro 3D tumor microtissue model